bpc-157 safety fda status Just Cleared a Major Regulatory Hurdle If you've been following the peptide world, you've probably heard the buzz about BPC-157. Here's what actually happened: ✓ An advisory committee voted to FDA to review 7 popular

The study noted potential regenerative effects on cartilage and suggested BPC-157 may reduce the need for surgical intervention in selected cases

PMID 15476449

The theoretical rationale for combining tirzepatide and sermorelin centers on addressing complementary aspects of metabolic health, though evidence supporting this approach remains largely theoretical rather than evidence-based

That being said, I think theres a spectrum of reasonable reactions to be had to this situation, none of which are Mike is totally innocent, or Mike is a cheater. Its fair to say that Mike should have been aware that BPC-157 was on WADAs list of banned substances